Target intelligence / Profile preview

Iron- and copper-dependent enzymes

Molecular classification
Enzyme, Metalloenzyme, Oxidoreductase
01

Overview

Iron- and copper-dependent enzymes are a broad class of metalloproteins that utilize iron (Fe2+/Fe3+) or copper (Cu2+/Cu+) ions as essential cofactors to catalyze a wide range of biochemical reactions (Andreini et al., 2008). These enzymes play pivotal roles in fundamental biological processes such as cellular respiration, DNA synthesis, oxygen transport, and the neutralization of reactive oxygen species (Festa & Thiele, 2011). For instance, iron-dependent prolyl hydroxylases regulate the cellular response to hypoxia, while copper-dependent lysyl oxidases are required for the structural integrity of the extracellular matrix (Kagan & Li, 2003). Dysregulation of these enzymes or the homeostasis of their metal cofactors is implicated in various pathologies, including cancer, neurodegenerative diseases like Alzheimer's, and chronic inflammatory conditions (Bush, 2003). Therapeutic strategies targeting this group include small-molecule inhibitors that bind to the enzyme's active site or chelating agents that sequester the metal cofactors (Hentze et al., 2004). However, the broad distribution and essential nature of these metals across many physiological systems present significant challenges for achieving drug selectivity and minimizing systemic toxicity (Kim et al., 2008).

Other names
MetalloenzymesFe/Cu-dependent enzymesIron-dependent enzymesCopper-dependent enzymesMetal-dependent oxidoreductases
02

Mechanism of action

Inhibition of catalytic activity via active site binding or metal cofactor chelation (Kim et al., 2008).

03

Biological functions

Redox catalysisOxygen transportCellular respirationCollagen cross-linkingNeurotransmitter synthesisAntioxidant defense
04

Disease associations

CancerNeurodegenerative diseaseInflammationCardiovascular diseaseWilson's diseaseMenkes diseaseAnemia
05

Safety considerations

Systemic metal deficiencyOff-target metalloenzyme inhibitionNeurotoxicityHematological toxicityImpaired connective tissue repairGastrointestinal distress
06

Interacting drugs

Roxadustat

9 more in the full profile.

07

Biomarkers

Serum ferritinCeruloplasminHIF-1alpha protein levelsSerum copper8-hydroxy-2'-deoxyguanosine (8-OHdG)Transferrin saturation

Beyond the preview

Go deeper on Iron- and copper-dependent enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iron- and copper-dependent enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call